Last reviewed · How we verify

minor skin irritations — Treatment Landscape & Competitive Intelligence

minor skin irritations (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating minor skin irritations, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
First Aid 4pc MIni Stick Kit MYRRH Spry Life LLC
The Melanin Skin Protectant Cream LAUROCAPRAM Reedfresh Co., LTD Amide Local Anesthetic [EPC]

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Reedfresh Co., LTD · 1 drug in minor skin irritations
  2. Spry Life LLC · 1 drug in minor skin irritations

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in minor skin irritations:

Cite this brief

Drug Landscape (2026). minor skin irritations — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/minor-skin-irritations. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing